Molecular cloning and biochemical characterization of Xaa-Pro dipeptidyl-peptidase from Streptococcus mutans and its inhibition by anti-human DPP IV drugs

作者：De Arpan; Lupidi Giulio; Petrelli Dezemona; Vitali Luca A^*

来源：FEMS Microbiology Letters, 2016, 363(9): fnw066.

DOI：10.1093/femsle/fnw066

• Serine protease
• protein purification
• nisin induction
• gliptins
• enzyme inhibition

Streptococcus mutans harbours an intracellular, human DPP IV-analogous enzyme Xaa-Pro dipeptidyl-peptidase (EC 3.4.14.11). According to previous reports, an extracellular isozyme in S. gordonii and S. suis has been associated with virulence. Speculating that even an intracellular form may aid in virulence of S. mutans, we have tried to purify, characterize and evaluate enzyme inhibition by specific inhibitors. The native enzyme was partially purified by ion-exchange and gel filtration chromatography. Owing to low yield, the enzyme was overexpressed in Lactococcus lactis and purified by affinity chromatography. The recombinant enzyme (rSm-XPDAP) had a specific activity of 1070 U mg(-1), while the V-max and K-m were 7 mu M min(-1) and 89 +/- 7 mu M (n = 3), respectively. The serine protease inhibitor phenylmethylsulphonyl fluoride and a DPP IV-specific inhibitor diprotin A proved to be active against rSm-XPDAP. As a novel approach, the evaluation of the effect of anti-human DPP IV (AHD) drugs on rSm-XPDAP activity found saxagliptin to be effective to some extent (K-i = 129 +/- 16 mu M), which may lead to the synthesis and development of a new class of antimicrobial agents.

• 出版日期2016-5